Tourmaline Bio Inc. (TRML) — Net Asset Quality Index
Tourmaline Bio Inc. (TRML) has a Net Asset Quality Index of 96.2% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $269.30 Million minus total liabilities of $10.10 Million yields net assets of $259.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check TRML asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Tourmaline Bio Inc. Net Asset Quality Index Over Time (2019–2024)
This chart shows how Tourmaline Bio Inc.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the index stands at 96.2%, representing net assets of $259.19 Million against total assets of $269.30 Million USD. See Tourmaline Bio Inc. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Tourmaline Bio Inc. (2019–2024)
The table below presents the year-by-year Net Asset Quality Index for Tourmaline Bio Inc. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see TRML market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.1% | $300.05 Million | $309.00 Million | $8.95 Million | ▼ -0.4 pp |
| 2023 | 97.5% | $205.04 Million | $210.29 Million | $5.25 Million | ▲ +314.4 pp |
| 2022 | -216.9% | $-19.73 Million | $9.10 Million | $28.83 Million | ▼ -313.5 pp |
| 2021 | 96.6% | $242.81 Million | $251.42 Million | $8.61 Million | ▼ -0.3 pp |
| 2020 | 96.9% | $148.00 Million | $152.78 Million | $4.77 Million | ▲ +2.5 pp |
| 2019 | 94.4% | $39.59 Million | $41.94 Million | $2.35 Million | — |